It is potentially a huge amount of milestones in the chest but...

It is potentially a huge amount of milestones in the chest but what we also need to consider is each of those milestones are very long term to reach the full consideration of any that are succesful, unless of course for those that are only carrying a predeveloped drug where i'd assume the required trials would likely be half. On discovery front though & considering PYC role is preclinical then access to the full milestone on many if not all would somewhere around the 10 year mark using the consensus discovery to approval timeline of new drugs. PW's near 100% success rate was indeed impressive but i guess it has to be remembered that it is referring to meeting the objectives laid out it's not a near 100% success rate of eventually leading to a new drug, that will be largely in the pharmas hands & dependent on the many stages still to come will determine how much of the milestones are achieved. The timelines laid out the presentation did seem to outline it fairly well though with the "rough" estimates of potential cash made available at each stage - it's clear to see from there that the bulk of the milestones only due once the drug is approved & at market much further down the track. Still wouldn't be compalining at all if the companby is able to line up 1 or 2 single digit mil payments later this year or early next. I think it's all coming together but it just needs a lot of patience from investors that want to see the rewards.